Evaluation of Genetic Patterns in Different Tumor Areas of Intermediate-Grade Prostatic Adenocarcinomas by High-Resolution Genomic Array Analysis

Genes Chromosomes and Cancer

Volumn 39, Issue 3, 2004, Pages 249-256

  Van Dekken, Herman ^a   Paris, Pamela L ^b   Albertson, Donna G ^b   Alers, Janneke C ^a   Andaya, Armann ^b   Kowbel, David ^b   Van Der Kwast, Theodorus H ^a   Pinkel, Daniel ^b   Schröder, Fritz H ^a   Vissers, Kees J ^a   Wildhagen, Mark F ^a   Collins, Colin ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FORMALDEHYDE; PARAFFIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CHROMOSOME ANALYSIS; CLASSIFICATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOGENETICS; DNA MICROARRAY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; TARGET CELL;

ADENOCARCINOMA; AGED; CYTOGENETIC ANALYSIS; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS;

EID: 10744220165     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20001     Document Type: Article

References (44)

1. Alers JC, Krijtenburg PJ, Vissers CJ, Bosman FT, van der Kwast ThH, van Dekken H. 1995a. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancers. Cytometry 21:84-94.
2. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast ThH, van Dekken H. 1995b. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent intraepithelial neoplasias (PIN). Genes Chromosomes Cancer 12:241-250.
3. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WCJ, Verkerk AM, Schröder FH, van der Kwast ThH, Bosman FT, van Dekken H. 1997. Interphase cytogenetics of prostatic tumor progression: Specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 77:437-448.
4. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WCJ, van der Kwast ThH, Schröder FH, Tanke HJ, van Dekken H. 2001. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: Early cancers may contain aggressive genetic features. Am J Pathol 158:399-406.
5. Bostwick DG. 1995. High grade prostatic intraepithelial neoplasia. Cancer 75:1823-1836.
6. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L. 1998. Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma. Cancer 83:1995-2002.
7. Brothman AR, Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladega LE, Schellhammer PF. 1991. Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84.
8. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. 1999. Chromosomal clues to the development of prostate tumors. Prostate 38:303-312.
9. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi O-P. 1999. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59:803-806.
10. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization. Cancer Res 56:3091-3102.
11. Cooney KA, Wetzel JC, Meravjer SD, Macoska JA, Singleton TP, Woyno KJ. 1996. Distinct regions of allelic loss on 13q in prostate cancer: Cancer Res 56:1142-1145.
12. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN. 1996. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56:4475-4482.
13. Gleason DF. 1992. Histologic grading of prostate cancer. Hum Pathol 23:273-279.
14. Henke RP, Kruger E, Ayhan N, Hubner D, Hammerer P. 1994. Frequency and distribution of numerical chromosomal aberrations in prostatic cancer. Hum Pathol 25:476-484.
15. Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH. 2000. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. J Urol 164:411-415.
16. Huang SF, Xiao S, Renshaw AA, Loughlin KR, Hudson TJ, Fletcher JA. 1996. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am J Pathol 149:1565-1573.
17. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. 2002. Fully automatic quantification of microarray image data. Genome Res 12:325-332.
18. Jenkins RB, Qian J, Lieber MM, Bostwick DG. 1997. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 57:524-531.
19. Kucuk O, Demirer T, Gilman-Sachs A, Taw I, Mangold M, Singh S, Westerman MP. 1993. Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histological grade in prostate cancer. J Surg Oncol 54:171-174.
20. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. 1992. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 4:16-24.
21. Macintosh CA, Stower M, Reid N, Maitland NJ. 1998. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 56:23-28.
22. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell I-J, Pontes JE. 1994. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830.
23. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata D, Cote RJ, Roy-Burman P. 1995. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol 147:92-101.
24. Nowell PC. 1976. The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlines tumor progression. Science 194:23-28.
25. O'Malley FP, Grignon DJ, Keeney M, Kerkvliet N, McLean C. 1993. DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate. Cancer 71:2797-2802.
26. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJE, Wildhagen MF, Collins C, van Dekken H. 2003. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol 162:763-770.
27. Perinchery G, Bukurov N, Nakajima K, Chang J, Li L-C, Dahiya R. 1999. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer. Int J Cancer 83:610-614.
28. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee, SH, Ljung B-M, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
29. Potosky AL, Miller BA, Albertsen PC, Kramer BS. 1995. The role of increasing detection in the rising incidence of prostate cancer. J Am Med Assoc 273:548-552.
30. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. 1996. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180:295-299.
31. Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers M, Debruyne FM, Ruiter DJ, Schalken JA. 1999. Molecular analysis of multifocal prostate cancer lesions. J Pathol 188:271-277.
32. Saric T, Brkanac Z, Troyer DA, Padalecki SS, Sarosdy M, Williams K, Abadesco L, Leach RJ, O'Connell P. 1999. Genetic pattern of prostate cancer progression. Int J Cancer 81:219-224.
33. Schröder FH, van der Maas P, Beemsterboer P, Boeken Kruger A, Hoedemaeker R, Rietbergen J, Kranse R. 1998. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 90:1817-1823.
34. Shankey TV, Jin JK, Dougherty S, Flanigan RC, Graham S, Pyle JM. 1995. DNA ploidy and proliferation heterogeneity in human prostate cancers. Cytometry 21:30-39.
35. Skacel M, Ormsby AH, Pettay JD, Tsiftsakis EK, Liou LS, Klein EA, Levin HS, Zippe CD, Tubbs RR. 2001. Aneusomy of chromosomes 7, 8 and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Hum Pathol 32:1392-1397.
36. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG. 2001. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29:263-264.
37. Sobin LH, Wittekind Ch. 2002. TNM classification of malignant tumours: International Union Against Cancer (UICC). 6th ed. New York: Wiley-Liss. p 184-187.
38. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS. 1998. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58:204-209.
39. Van Dekken H, Rosenberg C, Krijtenburg PJ, Alers JC. 1997. Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions. Histochem Cell Biol 108:409-430.
40. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P. 1995. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
41. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Lioatta LA, Emmert-Buck MR, Linehan WM. 1996. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-p21. Cancer Res 56:2411-2416.
42. Warzynski MJ, Soechtig CE, Maatman TJ, Goldsmith LC, Grobbel MA, Carothers GC, Shochley KF. 1995. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma-necessitating multiple site analysis. Prostate 27:329-335.
43. Wessendorf S, Fritz B, Wrobel G, Nessling M, Lampel S, Goettel D, Kuepper M, Joos S, Hopman T, Kokocinski F, Dohner H, Bentz M, Schwaenen C, Lichter P. 2002. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Invest 82:47-60.
44. Zitzelsberger H, Kulka U, Lehmann L, Walch A, Smida J, Aubele M, Lorch T, Hofler H, Bauchinger M, Werner M. 1998. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primer PCR and comparative genomic hybridization. Virchows Arch 433:297-304.